期刊文献+

益肺解毒方对老年晚期肺癌患者生存质量的影响 被引量:13

Effect of Yifei Jiedu Formula on Quality of Life of Elderly Patients with Advanced Lung Cancer
下载PDF
导出
摘要 目的:观察益肺解毒方对老年晚期非小细胞肺癌患者的生存质量的影响。方法:将63例老年晚期非小细胞肺癌患者随机分为中医组、化疗组、中西医结合组,中医组治以益肺解毒方,化疗组治以第三代细胞毒药物单药(吉西他滨或长春瑞滨或多西他赛)化疗。治疗时间为2个周期,以ECOG行为状态评分和EORTCQLQC-30量表为工具评价益肺解毒方对老年晚期非小细胞肺癌患者的生存质量的影响。中西组治化疗的同时加用中药。结果:中医组治疗后躯体功能、角色功能、情绪功能、疲倦、疼痛、呼吸困难、食欲丧失、大便异常等指标计分下降,与治疗前比较具有统计学差异(P<0.05或P<0.01);总健康状况计分提高,具有显著地统计学差异(P<0.05);行为状态评分有效率为85.71%;化疗组治疗后躯体功能、角色功能、情绪功能、认知功能、社会功能各维度以及疲倦、恶心呕吐、食欲丧失、大便异常、经济负担等状况的计分均较治疗前上升(P<0.05或P<0.01),行为状态评分有效率为65.00%。中西医组治疗后情绪功能明显下降(P<0.01),疲倦、恶心呕吐、经济负担的计分明显上升(P>0.05).且情绪功能积分下降与化疗组比较有显著差异(P<0.01)。化疗组组、中西医组治疗后恶心呕吐分均提高,治疗前后具有显著统计学差异(P<0.01),两组间比较无统计学差异(P>0.05)。化疗组与中医组比较在社会功能、疲倦、恶心呕吐、大便异常存在统计学差异(P<0.05或P<0.01)。结论:益肺解毒方能改善老年晚期非小细胞肺癌患者的生存质量。 Objective:To observe the effect of Yifei Jiedu Formula on quality of life of elderly patients with advanced non-small cell lung cancer.Methods:Sixty-three elderly patients with advanced non-small cell lung cancer were randomly divided into traditional Chinese medicine group,chemotherapy group,integrative medicine group.Traditional Chinese medicine group was treated with Yifei Jiedu Formula,chemotherapy group with a single third-generation cytotoxic drug(gemcitabine or Changchun vinorelbine or docetaxel) chemotherapy,integrative medicine group with chemotherapy plus Chinese medicine.Treatment time was 2 cycles,with ECOG performance status and EORTCQLQC-30 scale as a tool to evaluate the effect on quality of life of elderly patients with advanced non-small cell lung cancer.Results:After treatment,Chinese medicine physical function,role function,emotional function,fatigue,pain,difficulty breathing,loss of appetite,abnormal stools and other indicators were declined,compared with those before treatment there was a statistically significant difference(P〈0.05 or P〈0.01);total health points were increased,with a statistically significant difference(P〈0.05);performance status score effective rate was 85.71%.In chemotherapy group:physical function,role function,emotional function,cognitive function,social function of dimensions,as well as fatigue,nausea,vomiting,loss of appetite,abnormal stools,economic and other conditions of the scoring burden were increased(P〈0.05 or P〈0.01),performance status score rate was 65.00%.In integrative medicine group after treatment,emotional function was decreased significantly(P〈0.01),fatigue,nausea,vomiting and economic burden score were significantly increased(P〈0.05).And emotional function score decreased with the chemotherapy group were significantly different(P〈0.01).In chemotherapy group and integrative medicine group after treatment,nausea and vomiting scores were improved after treatment with a statistically significant difference(P〈0.01),but there was no significant difference between the two groups(P〈0.05).Chemotherapy group and Chinese medicine group had significant differences in group social functions,fatigue,nausea,vomiting and abnormal stools(P〈0.05 or P〈0.01).Conclusion:Yifei Jiedu Formula can improve quality of life of elderly patients with advanced non-small cell lung cancer patients.
出处 《辽宁中医杂志》 CAS 2012年第11期2176-2178,共3页 Liaoning Journal of Traditional Chinese Medicine
基金 黑龙江省卫生厅课题(2011-275)
关键词 老年 肺癌 益肺解毒方 生存质量 elderly lung cancer Yifei Jiedu Formula quality of life
  • 相关文献

参考文献7

  • 1Fry WA, Phillips JL, Menck HR. Ten-year survey of lung cancer treatment and survival in hospitals in the United States:a national cancer data base report [ J ]. Cancer, 1999,86 : 1867 - 76.
  • 2吴一龙,Tony Mok.胸部肿瘤分期手册[M].7版.北京:人民卫生出版社,2010.
  • 3Schipper H, Clinch J, McMurray A, et al. Measuring the quality of life of cancer petiants: The Functional Living Index-Cancer: development and validation [ J ]. Journal of Clinical Oncology, 1984,2 ( 5 ) : 472 - 483.
  • 4Okee MM, Creen RH,Tormey DC,et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group [ J ]. Am J Clin Oncol, 1982,5(6) :649 -655.
  • 5罗健,孙燕.癌症患者生活质量研究[J].中国肿瘤,2001,10(2):76-78. 被引量:172
  • 6刘嘉湘.辨证治疗原发性肺癌310例疗效分析[J].上海中医药杂志,1985,(10):3-3.
  • 7刘嘉湘,施志明,李和根,徐振晔,朱晏伟,赵丽红,高虹,刘苓霜,朱惠蓉,张晖.益肺抗瘤饮治疗271例非小细胞肺癌临床观察[J].上海中医药杂志,2001,35(2):4-6. 被引量:93

共引文献286

同被引文献68

  • 1黄旭龙,郝俊杰,徐锋,王祥培,吴红梅.基于网络药理学预测天冬活性成分抗肿瘤分子作用机制的研究[J].中药材,2019(9):2142-2150. 被引量:6
  • 2徐力.中药诱导肿瘤细胞凋亡中医机制探析[J].新中医,2005,37(10):5-6. 被引量:5
  • 3杨绍杰,孟金萍,屈祎,刘云波.细胞凋亡信号传导通路的研究进展[J].中国比较医学杂志,2007,17(5):297-301. 被引量:72
  • 4Brunelli A, Salati M, Refai M. Development of a patient-centered aggregate score to predict survival after lung resection for non-small cell lung cancer [J]. J Thorac Cardiovasc Surg,2013.
  • 5Reich JM, Kim JS, Asaph JW. Survival in untreated stage I lung cancer [J]. Chest,2013, May;143(5) :1518 - 1518.
  • 6Fiorelli A, Santini M. In lung cancer patients where a malignant pleural effusion is found at operation could resection ever still be justified [ J]. Interact Cardiovasc Thorac Surg, 2013.
  • 7Botana-Rial M, Leiro-Fernandez V, Represas-Represas C. Thorac- ic Ultrasound-Assisted selection for pleural blopsy with abrams nee- die[ J]. Respir Care,2013.
  • 8Weibel S, Hofmann E, Basse-Luesebrink TC. Treatment of malig- nant effusion by oncolytic virotherapy in an experimental subcutane- ous xenograft model of lung cancer [ J]. J Transl Med, 2013, 11: 106 - 106.
  • 9Bernard W. Stewart, Christopher P. Wild. World cancer report 2014 [ M ]. IARC Press, International Agency for Research on Cancer,2014.
  • 10Jemal A,Siegel R,Ward E,et al. Cancer statistics [J]. CA Cancer J Clin,2009,59 (4) :225 - 249.

引证文献13

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部